HSPA9 and ovarian carcinoma: Compared with a low‐grade ovarian cancer cell line (OV‐90 and CAOV‐3), metastatic tumour cells (COC1) and cisplatin‐resistant ovarian cancer cells (A2780/cis) have elevated mortalin expression.